Article Details

Cara Therapeutics (NASDAQ:CARA) Stock Price Down 13.4%

Retrieved on: 2019-07-25 18:07:30

Tags for this article:

Click the tags to see associated articles and topics

Cara Therapeutics (NASDAQ:CARA) Stock Price Down 13.4%. View article details on HISWAI:

Excerpt

<div><b>Two Sigma Investments</b> LP purchased a new stake in shares of Cara Therapeutics during the 4th quarter valued at $1,578,000. BlackRock Inc. lifted ...</div>

Article found on:

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up